Clinical Trial Update: Feasibility of Vaginal Progesterone to Reduce HIV-Associated Preterm Birth [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial evaluating the feasibility of vaginal progesterone to reduce preterm birth in HIV-associated pregnancies has completed with posted resu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Preterm Birth

Drugs mentioned

• PROGESTERONE (Progesterone)

Snippet

Sponsor: University of North Carolina, Chapel Hill | Conditions: PreTerm Birth | Phase 4 | Status: COMPLETED | Results posted: 2020-02-06